超声乳化治疗糖尿病患者白内障的临床分析

Clinical analysis of treating of cataracts diabetic with phacoemulsification

目的探讨糖尿病患者白内障进行超声乳化吸出人工晶状体植入术的疗效和并发症。方法对42例(46眼)糖尿病患者的白内障施行3.5mm角巩膜隧道切口,晶状体超声乳化吸出,植入折叠式人工晶状体。结果术后1天视力≥0.6者28眼(60.87%);术后3月视力≥1.0者27眼(58.7%)。术后1月角膜散光平均为(1.12±0.48)D,与术前对比,差异无统计学意义(P>0.05)。术中后囊破裂1眼;术后轻度角膜水肿7眼(15.22%),房水闪光5眼(10.87%),均于1周内消退;后囊浑浊1眼。结论采用晶状体超声乳化吸出折叠式人工晶状体植入术治疗糖尿病患者的白内障,术后并发症较少,视力恢复尚好,手术是安全的、有效的。

Objective To investigate the clinical therapeutic effect and complications of treating of cataracts diabetic with phacoemulsification and intraocular lens （IOL） implantation. Methods 42 cases （46 eyes） of diabetic cataract underwent phacoemulsification and foldable IOL implantation through a 3.5mm limbus tunnel incision. Results The visual acuity was 0.6 in 28 eyes （60.9%） after one day, a 1.0 in 27 eyes （58.7%） after 3 months. Corneal astigmatism degree and complications was less after surgery. Conclusions The postoperative complications was less and the visual acuity recruited rapidly. It was safe and effective to diabetics.